These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27881716)

  • 41. Efflux of cellular cholesterol and phospholipid to apolipoprotein A-I mutants.
    Sviridov D; Pyle LE; Fidge N
    J Biol Chem; 1996 Dec; 271(52):33277-83. PubMed ID: 8969186
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The 5A apolipoprotein A-I mimetic peptide displays antiinflammatory and antioxidant properties in vivo and in vitro.
    Tabet F; Remaley AT; Segaliny AI; Millet J; Yan L; Nakhla S; Barter PJ; Rye KA; Lambert G
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):246-52. PubMed ID: 19965776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Removal of cellular cholesterol by pre-beta-HDL involves plasma membrane microsolubilization.
    Gillotte KL; Davidson WS; Lund-Katz S; Rothblat GH; Phillips MC
    J Lipid Res; 1998 Oct; 39(10):1918-28. PubMed ID: 9788238
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current models of apolipoprotein A-I lipidation by adenosine triphosphate binding cassette transporter A1.
    Hafiane A; Gianopoulos I; Sorci-Thomas MG; Daskalopoulou SS
    Curr Opin Lipidol; 2022 Apr; 33(2):139-145. PubMed ID: 34581311
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The lipidation by hepatocytes of human apolipoprotein A-I occurs by both ABCA1-dependent and -independent pathways.
    Kiss RS; McManus DC; Franklin V; Tan WL; McKenzie A; Chimini G; Marcel YL
    J Biol Chem; 2003 Mar; 278(12):10119-27. PubMed ID: 12547832
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intracellular cholesterol mobilization involved in the ABCA1/apolipoprotein-mediated assembly of high density lipoprotein in fibroblasts.
    Yamauchi Y; Chang CC; Hayashi M; Abe-Dohmae S; Reid PC; Chang TY; Yokoyama S
    J Lipid Res; 2004 Oct; 45(10):1943-51. PubMed ID: 15292375
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of lipid transfer protein on plasma lipids, apolipoproteins and metabolism of high-density lipoprotein cholesteryl ester in the rat.
    Groener JE; van Gent T; van Tol A
    Biochim Biophys Acta; 1989 Mar; 1002(1):93-100. PubMed ID: 2493808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deletion of the propeptide of apolipoprotein A-I reduces protein expression but stimulates effective conversion of prebeta-high density lipoprotein to alpha-high density lipoprotein.
    Sviridov D; Pyle LE; Jauhiainen M; Ehnholm C; Fidge NH
    J Lipid Res; 2000 Nov; 41(11):1872-82. PubMed ID: 11060357
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oxidation of methionine residues to methionine sulfoxides does not decrease potential antiatherogenic properties of apolipoprotein A-I.
    Panzenböck U; Kritharides L; Raftery M; Rye KA; Stocker R
    J Biol Chem; 2000 Jun; 275(26):19536-44. PubMed ID: 10751387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myeloperoxidase-derived oxidants modify apolipoprotein A-I and generate dysfunctional high-density lipoproteins: comparison of hypothiocyanous acid (HOSCN) with hypochlorous acid (HOCl).
    Hadfield KA; Pattison DI; Brown BE; Hou L; Rye KA; Davies MJ; Hawkins CL
    Biochem J; 2013 Jan; 449(2):531-42. PubMed ID: 23088652
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Remodeling of HDL containing apoA-I but not apoA-II (LpA-I) by lipoprotein-deficient plasma and hepatic lipase: its effect on the structure and cellular cholesterol-reducing capacity of LpA-I.
    Ohta T; Ikeda Y; Hattori S; Matsuda I
    Biochim Biophys Acta; 1996 Sep; 1303(2):137-44. PubMed ID: 8856043
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ApoA-IV metabolism in the rat: role of lipoprotein lipase and apolipoprotein transfer.
    Lefevre M; Chuang MY; Roheim PS
    J Lipid Res; 1986 Nov; 27(11):1163-73. PubMed ID: 3559382
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid.
    Lindholm EM; Bielicki JK; Curtiss LK; Rubin EM; Forte TM
    Biochemistry; 1998 Apr; 37(14):4863-8. PubMed ID: 9538003
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice.
    Amar MJ; D'Souza W; Turner S; Demosky S; Sviridov D; Stonik J; Luchoomun J; Voogt J; Hellerstein M; Sviridov D; Remaley AT
    J Pharmacol Exp Ther; 2010 Aug; 334(2):634-41. PubMed ID: 20484557
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of free apolipoprotein A-I in cholesterol efflux. Formation of pre-alpha-migrating high-density lipoprotein particles.
    Asztalos B; Zhang W; Roheim PS; Wong L
    Arterioscler Thromb Vasc Biol; 1997 Sep; 17(9):1630-6. PubMed ID: 9327755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts.
    Miettinen HE; Jauhiainen M; Gylling H; Ehnholm S; Palomäki A; Miettinen TA; Kontula K
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3021-32. PubMed ID: 9409289
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intracellular lipidation of newly synthesized apolipoprotein A-I in primary murine hepatocytes.
    Maric J; Kiss RS; Franklin V; Marcel YL
    J Biol Chem; 2005 Dec; 280(48):39942-9. PubMed ID: 16204232
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human apoA-I expression in CETP transgenic rats leads to lower levels of apoC-I in HDL and to magnification of CETP-mediated lipoprotein changes.
    Masson D; Pais de Barros JP; Zak Z; Gautier T; Le Guern N; Assem M; Chisholm JW; Paterniti JR; Lagrost L
    J Lipid Res; 2006 Feb; 47(2):356-65. PubMed ID: 16282639
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lipid transfers between reconstituted high density lipoprotein complexes and low density lipoproteins: effects of plasma protein factors.
    Jonas A; Kézdy KE; Williams MI; Rye KA
    J Lipid Res; 1988 Oct; 29(10):1349-57. PubMed ID: 3148678
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel formulation of a reconstituted high-density lipoprotein (CSL112) dramatically enhances ABCA1-dependent cholesterol efflux.
    Diditchenko S; Gille A; Pragst I; Stadler D; Waelchli M; Hamilton R; Leis A; Wright SD
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2202-11. PubMed ID: 23868939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.